Tranostat-MF 10 Tablets

babies: it does not apply to babies. lactating mother: it is safe to use this medication during breastfeeding.
human studies have shown that this drug may not pass into breastmilk and may not harm the baby. pregnancy: tranexamic acid, the mefenamic acid tablet, is unsafe to use during pregnancy.
some limited human and animal studies suggest that this drug may cause harmful effects on developing babies. consult your doctor.
alcohol: it is unsafe to consume alcohol while taking this medication. driving: tranexamic acid, mefenamic acid tablets may reduce alertness, affect your vision and make you feel sleepy or dizzy.
do not drive if these symptoms occur. liver: it is safe to use this medication in patients with liver disease.
dose adjustment is not required. consult your doctor.
kidney: this medication should be used with caution in patients with kidney disease. you may require dose adjustment.
consult your doctor..

Nausea Vomiting Diarrhea Loss of appetite Nasal congestion Musculoskeletal pain Sinus pain and inflammation.

tranexamic acid in TRANOSTAT-MF tablets is an anti-fibrinolytic. it works by controlling excessive bleeding during periods.
mefenamic acid is a non-steroidal anti-inflammatory drug (nsaid). it works by blocking the production of certain chemical messengers which cause pain and inflammation..

If you miss a dose in TRANOSTAT-MF tablets, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• TRANOSTAT-MF tablets is used to treat heavy menstrual bleeding and menstrual pain • take it with food to avoid stomach upset • inform your doctor, if you have kidney or liver disease • consult your doctor if there is no improvement in bleeding even after taking this medication • take it on the first day of a heavy period • drink plenty of water to prevent dehydration.

• mefenamic acid + ketorolac: concurrent use may result in enhanced gastrointestinal adverse effects • mefenamic acid + aceclofenac: concurrent use may result in an increased risk of bleeding • mefenamic acid + benzthiazide: concurrent use may result in reduced diuretic effectiveness and possible nephrotoxicity • mefenamic acid + celecoxib: concurrent use may result in an increased risk of bleeding • mefenamic acid + timolol: concurrent use may result in increased blood pressure • tranexamic acid + desogestrel: concurrent use result in an increased risk of thrombic events • tranexamic acid + estradiol: concurrent use may result in an increased risk of thrombic events • tranexamic acid + norgestimate: concurrent use may result in an increased risk of thrombic events • tranexamic acid + chlorpromazine: concurrent use may result in an increased risk of bleeding • tranexamic acid + tretinoin: concurrent use may result in an increased risk of thrombosis.